FDA expands approval for clonoSEQ assay to detect MRD in CLL patients
The FDA previously granted a De Novo designation for the assay to detect MRD in patients with multiple…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Aug 20
The FDA previously granted a De Novo designation for the assay to detect MRD in patients with multiple…
07 Aug 20
Curated menu of Off-the-Shelf RNAscope probes provide seamless molecularly-guided region of interest selection for use with the new…
06 Aug 20
The high-throughput molecular diagnostic testing system has the capacity to analyse up to 6,000 samples in a single…
06 Aug 20
The probe-based reverse transcription PCR test will allow to identify SARS-CoV-2 by targeting conserved regions of the viral…
06 Aug 20
The company's Sight OLO analyser is designed to automate the identification and quantification of various blood cell types…
06 Aug 20
Along with sentinel assays, pooled testing will be another integral tool in Eurofins’ comprehensive SARS-CoV-2 SAFER WORKTM programme
06 Aug 20
The clinical testing is aimed at supporting the regulatory submission for the US Food and Drug Administration (FDA)…
06 Aug 20
MeMD is a comprehensive telehealth solution providing on-demand, online care for common illnesses, injuries and behavioral health issues…
05 Aug 20
Eurofins GeneScan Technologies, a proven leader in bio-molecular testing committed to the highest quality standards and technical excellence…
04 Aug 20
The PICKUP study will evaluate the additive diagnostic value of the Karius test in the diagnosis of pneumonia